Status:
COMPLETED
Newly Diagnosed With Inflammatory Arthritis - a Self-management Intervention (NISMA)
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Conditions:
Feasibility
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Even though medical treatment has improved within the last 10-15 years, patients with inflammatory arthritis (IA) still experience reduced quality of life, depression, anxiety, changes in family roles...
Detailed Description
RATIONALE FOR NISMA PROJECT The hypothesis is that a self-management intervention can help patients develop behavioral and emotional strategies to manage life with arthritis. There a lack of disease-...
Eligibility Criteria
Inclusion
- Adult persons (≥18 years)
- Diagnosed with one of the following diagnoses: Rheumatoid arthritis (ICD10 diagnoses: M05.3, M05.9, M05.8, M06.9), Spondyloarthritis (ICD10 diagnoses: M45.9, M46.1, M46.8, M46.9) or Psoriatic arthritis (ICD10 diagnoses: M073.A, M073.B), within the last 6 months.
Exclusion
- Insufficient language skills to discuss the topics in the intervention in Danish
- In chemotherapy treatment for malignancies
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 23 2023
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT06063252
Start Date
November 1 2021
End Date
April 23 2023
Last Update
October 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Luise Holberg Lindgren
Glostrup Municipality, Capital Region, Denmark, 2600